Skip to page content

Schizophrenia

Drug Markets and Supply
commentary
What Will the Opioid Crisis Look Like in Five Years?
Jirka Taylor, Peter Reuter
Nov 18, 2019
Concord Monitor in New Hampshire
Despite variations in European opioid markets, there is an overarching commonality too: Once a synthetic opioid like fentanyl becomes dominant, it stays that way. The United States should prepare for fentanyl and other synthetic opioids as a lasting phenomenon. Learning from other countries' experiences is an important part of that effort.
Read More »

Schizophrenia
commentary
Patients with Severe Schizophrenia Aren't Getting the Help They Need
Adam J. Rose
Jul 25, 2016
Health Affairs Blog
Clozapine has proven effective for patients with treatment-resistant schizophrenia, but the health system is poorly configured to provide it. The drug has possible side effects that require extra patient monitoring, but it saves costs by reducing hospitalizations.
Read More »
Primary Care
commentary
Improving Physical Health Care for Adults with Serious Mental Illness
Deborah M. Scharf
Apr 14, 2014
The RAND Blog
A promising strategy for helping adults with serious mental illness gain access to appropriate primary and preventive medical services is to integrate those services into a setting in which the population already receives care.
Read More »